v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Follow on public offering
Common Stock
Common Stock
Follow on public offering
Additional Paid-in Capital
Additional Paid-in Capital
Follow on public offering
Accumulated Deficit
Accumulated Other Comprehensive Gain (Loss)
Beginning balance (in shares) at Dec. 31, 2024     124,893,034          
Beginning balance at Dec. 31, 2024 $ 3,305,819   $ 128   $ 4,697,883   $ (1,388,319) $ (3,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with employee incentive plans (in shares)     546,419          
Issuance of common stock in connection with employee incentive plans 6,049   $ 1   6,048      
Issuance of common stock in connection with follow-on public offering cost, net of commissions and offering expenses (in shares)       3,499,959        
Issuance of common stock and pre-funded warrants in connection with follow-on public offering cost, net of commissions and offering expenses   $ 0   $ 3   $ (3)    
Taxes paid related to the net share settlement of equity awards (5,290)       (5,290)      
Stock-based compensation expense 30,615       30,615      
Other comprehensive (loss) gain 3,551             3,551
Net loss (140,718)           (140,718)  
Ending balance (in shares) at Mar. 31, 2025     128,939,412          
Ending balance at Mar. 31, 2025 3,200,026   $ 132   4,729,253   (1,529,037) (322)
Beginning balance (in shares) at Dec. 31, 2024     124,893,034          
Beginning balance at Dec. 31, 2024 3,305,819   $ 128   4,697,883   (1,388,319) (3,873)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (307,291)              
Ending balance (in shares) at Jun. 30, 2025     129,816,472          
Ending balance at Jun. 30, 2025 3,071,334   $ 133   4,768,698   (1,695,610) (1,887)
Beginning balance (in shares) at Mar. 31, 2025     128,939,412          
Beginning balance at Mar. 31, 2025 3,200,026   $ 132   4,729,253   (1,529,037) (322)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with employee incentive plans (in shares)     236,375          
Issuance of common stock in connection with employee incentive plans 3,235       3,235      
Issuance of common stock in connection with follow-on public offering cost, net of commissions and offering expenses (in shares)       640,685        
Issuance of common stock and pre-funded warrants in connection with follow-on public offering cost, net of commissions and offering expenses   1   $ 1        
Taxes paid related to the net share settlement of equity awards (717)       (717)      
Stock-based compensation expense 36,927       36,927      
Other comprehensive (loss) gain (1,565)             (1,565)
Net loss (166,573)           (166,573)  
Ending balance (in shares) at Jun. 30, 2025     129,816,472          
Ending balance at Jun. 30, 2025 3,071,334   $ 133   4,768,698   (1,695,610) (1,887)
Beginning balance (in shares) at Dec. 31, 2025     131,058,858          
Beginning balance at Dec. 31, 2025 2,685,510   $ 134   4,838,736   (2,154,947) 1,587
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with employee incentive plans (in shares)     606,123          
Issuance of common stock in connection with employee incentive plans 9,032   $ 0   9,032      
Issuance of common stock in connection with follow-on public offering cost, net of commissions and offering expenses (in shares)       12,650,000        
Issuance of common stock and pre-funded warrants in connection with follow-on public offering cost, net of commissions and offering expenses   $ 601,846   $ 13   $ 601,833    
Taxes paid related to the net share settlement of equity awards (9,295)       (9,295)      
Stock-based compensation expense 37,964       37,964      
Other comprehensive (loss) gain (8,421)             (8,421)
Net loss (320,622)           (320,622)  
Ending balance (in shares) at Mar. 31, 2026     144,314,981          
Ending balance at Mar. 31, 2026 2,996,014   $ 147   5,478,270   (2,475,569) (6,834)
Beginning balance (in shares) at Dec. 31, 2025     131,058,858          
Beginning balance at Dec. 31, 2025 2,685,510   $ 134   4,838,736   (2,154,947) 1,587
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (604,924)              
Ending balance (in shares) at Jun. 30, 2026     144,785,934          
Ending balance at Jun. 30, 2026 2,757,942   $ 148   5,525,211   (2,759,871) (7,546)
Beginning balance (in shares) at Mar. 31, 2026     144,314,981          
Beginning balance at Mar. 31, 2026 2,996,014   $ 147   5,478,270   (2,475,569) (6,834)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with employee incentive plans (in shares)     470,953          
Issuance of common stock in connection with employee incentive plans 7,761   $ 1   7,760      
Taxes paid related to the net share settlement of equity awards (2,060)       (2,060)      
Stock-based compensation expense 41,241       41,241      
Other comprehensive (loss) gain (712)             (712)
Net loss (284,302)           (284,302)  
Ending balance (in shares) at Jun. 30, 2026     144,785,934          
Ending balance at Jun. 30, 2026 $ 2,757,942   $ 148   $ 5,525,211   $ (2,759,871) $ (7,546)